Metabolic Dysfunction‐Associated Steatotic Liver Disease (<scp>MASLD</scp>) Impacts Long‐Term Outcomes After Curative‐Intent Surgery for Hepatocellular Carcinoma
Patients with HCC undergoing LR and meeting the new MASLD criteria have significantly shorter OS. This study provides empirical prognostic evidence for the novel MASLD/MetALD classification in a large European cohort of patients undergoing curative-intent HCC therapy.
Authors
- Federico Collettini (ORCID: https://orcid.org/0000-0001-5378-461X)
- Isabella Lurje (ORCID: https://orcid.org/0000-0002-4006-7707)
- Ingrid W. Zhang (ORCID: https://orcid.org/0000-0001-6328-8257)
- Carolin Victoria Schneider (ORCID: https://orcid.org/0000-0002-6728-9246)
- Stefanie Herda
- Deniz Uluk (ORCID: https://orcid.org/0000-0001-6395-0845)
- Jairo Aldana-Bitar (ORCID: https://orcid.org/0000-0002-9407-7484)
- Dennis Eurich
- Frank Tacke (ORCID: https://orcid.org/0000-0001-6206-0226)
- Johann Pratschke (ORCID: https://orcid.org/0000-0001-9839-1369)
- Timo Alexander Auer (ORCID: https://orcid.org/0000-0002-5763-689X)
- Georg Lurje (ORCID: https://orcid.org/0000-0001-9674-0756)
- Frederik Schliephake
- Justus Pein (ORCID: https://orcid.org/0009-0003-4902-330X)
- Kevin L. Dreher
- Cornelius Engelmann
- Lukas Schaffrath
Institutions
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Charité - Universitätsmedizin Berlin (DE)
- RWTH Aachen University (DE)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1111/apt.70002
- Citations
- 8
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 10.83
Funders
- Deutsche Forschungsgemeinschaft